GlassScriptPhysician profile
Jimmy Jiang
NPI 1255652632
$6,351.62
in general payments reported to CMS, 2019-2025
44 companies · $1,356 in 2025
The $1,356 reported for 2025 was more than what 78% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,057 · 2020: $1,316 · 2021: $115 · 2022: $494 · 2023: $592 · 2024: $420 · 2025: $1,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,368.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,824.35 | 2019 | |
| United Orthopedics LLC | $1,120.34 | 2020-2024 | |
| Smith+Nephew, INC. | $889.57 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium, Q-Fix |
| Stryker Corporation | $622.80 | 2021-2025 | Blueprint Patient Specific Instrumentation, Mako, Aequalis Perform Reversed |
| Depuy Synthes Sales INC. | $175.84 | 2019-2025 | Truespan Orthocord, Dynacord, Rigidloop |
| Bioventus LLC | $136.02 | 2023-2025 | Xcell, Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $123.52 | 2019-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Horizon Therapeutics Plc | $114.60 | 2019-2021 | |
| Acera Surgical, INC. | $103.30 | 2025 | Restrata Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $92.43 | 2025 | |
| Anika Therapeutics, INC. | $81.13 | 2022-2025 | Integrity, Integrity Implant, Tactoset |
| Acumed LLC | $75.98 | 2019-2025 | Acumed, Acumed |
| Endo Pharmaceuticals INC. | $73.11 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $68.62 | 2023-2025 | Iovera, Exparel, Zilretta |
| Arthrosurface Incorporated | $64.81 | 2019-2020 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $64.33 | 2023 | |
| Integra Lifesciences Corporation | $58.85 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Illuminoss Medical, INC. | $58.10 | 2023-2025 | Photodynamic Bone Stabilization Procedure Pack |
| Medacta USA, INC. | $53.67 | 2022-2023 | Reverse Shoulder |
| Kowa Pharmaceuticals America, INC. | $50.85 | 2022-2023 | Seglentis |
| Innovation Technologies INC | $48.80 | 2025 | Irrisept |
| Davol INC. | $45.98 | 2025 | Arista |
| Moximed, INC | $38.48 | 2025 | Misha Knee System, Small, Left |
| Pacira Therapeutics, INC. | $26.99 | 2019-2020 | |
| Abbott Laboratories | $24.69 | 2024 | Proclaim |
| Organogenesis INC. | $24.20 | 2023 | Puraply |
| Solventum Corporation | $23.83 | 2025 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Biocomposites INC | $21.01 | 2021 | |
| Ferring Pharmaceuticals INC. | $20.63 | 2019 | |
| Endo USA, INC. | $19.96 | 2025 | Xiaflex |
| Trilliant Surgical LLC. | $19.90 | 2019 | |
| Vericel Corporation | $19.36 | 2025 | Maci |
| Arthrex, INC. | $18.20 | 2023 | Distal Extremities Implants Trauma Distal Radius |
| Polymedics Innovations INC. | $16.42 | 2023 | |
| Mimedx Group, INC. | $16.22 | 2025 | |
| Biotronik Nro, INC. | $15.72 | 2024 | |
| Osiris Therapeutics INC. | $15.38 | 2019 | |
| Reprise Biomedical, INC. | $15.18 | 2022 | |
| Zyla Life Sciences, INC. | $15.03 | 2019 | |
| Zimvie INC. | $14.82 | 2022 | |
| Sonex Health, INC. | $12.38 | 2024 | Sx-One Microknife |
| Assertio Therapeutics, INC. | $11.51 | 2020 | |
| Orthofix Medical, INC. | $9.63 | 2021 | |
| Paragon 28, INC. | $5.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jimmy Jiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.